Wound dressing
Latest Bristol-Myers squibb Company Patents:
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
- Substituted bicyclic compounds useful as T cell activators
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Description
FIG. 1 is a top plan view of a wound dressing, showing our new design;
FIG. 2 is an end elevation view thereof; and,
FIG. 3 is a bottom plan view thereof.
Claims
We claim the ornamental design for a wound dressing, as shown and described.
Referenced Cited
Patent History
Patent number: D501926
Type: Grant
Filed: Oct 7, 2003
Date of Patent: Feb 15, 2005
Assignee: Bristol-Myers squibb Company (New York, NY)
Inventors: Helen Shaw (Widnes), Patrick G. Linnane (Chester)
Primary Examiner: Ian Simmons
Attorney: John M. Kilcoyne
Application Number: 29/191,413
Type: Grant
Filed: Oct 7, 2003
Date of Patent: Feb 15, 2005
Assignee: Bristol-Myers squibb Company (New York, NY)
Inventors: Helen Shaw (Widnes), Patrick G. Linnane (Chester)
Primary Examiner: Ian Simmons
Attorney: John M. Kilcoyne
Application Number: 29/191,413
Classifications
Current U.S. Class:
Bandage For Protection Or Treatment (53) (D24/189)
